Core Cap Advisors, LLC Aurinia Pharmaceuticals Inc. Transaction History
Core Cap Advisors, LLC
- $2.07 Billion
- Q3 2024
A detailed history of Core Cap Advisors, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Core Cap Advisors, LLC holds 800 shares of AUPH stock, worth $6,400. This represents 0.0% of its overall portfolio holdings.
Number of Shares
800
Previous 800
-0.0%
Holding current value
$6,400
Previous $4,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AUPH
# of Institutions
209Shares Held
58.2MCall Options Held
1.14MPut Options Held
1.51M-
Black Rock Inc. New York, NY9.27MShares$74.2 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY8.2MShares$65.6 Million1.0% of portfolio
-
Tang Capital Management LLC San Diego, CA7.23MShares$57.8 Million4.52% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$31.8 Million2.22% of portfolio
-
State Street Corp Boston, MA2.95MShares$23.6 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.14B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...